These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 12670907

  • 1. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 2. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.
    Gaggioli C, Deckert M, Robert G, Abbe P, Batoz M, Ehrengruber MU, Ortonne JP, Ballotti R, Tartare-Deckert S.
    Oncogene; 2005 Feb 17; 24(8):1423-33. PubMed ID: 15608673
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
    Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG, Van Waes C, Chen Z.
    Cancer Res; 2005 Aug 15; 65(16):7071-80. PubMed ID: 16103054
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V.
    Oncogene; 2002 Apr 04; 21(15):2309-19. PubMed ID: 11948414
    [Abstract] [Full Text] [Related]

  • 6. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW, Chen Q, Zarnegar R.
    Oncogene; 2000 Feb 24; 19(9):1132-7. PubMed ID: 10713700
    [Abstract] [Full Text] [Related]

  • 8. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway.
    Bea F, Puolakkainen MH, McMillen T, Hudson FN, Mackman N, Kuo CC, Campbell LA, Rosenfeld ME.
    Circ Res; 2003 Mar 07; 92(4):394-401. PubMed ID: 12600889
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH.
    Hepatology; 2002 Nov 07; 36(5):1089-97. PubMed ID: 12395318
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E, Salani M, Anastasi S, Perroteau I, Poiana G, Biagioni S, Augusti-Tocco G.
    J Neurosci Res; 2003 Dec 01; 74(5):760-8. PubMed ID: 14635227
    [Abstract] [Full Text] [Related]

  • 11. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 12. Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2.
    Sakaue M, Adachi H, Dawson M, Jetten AM.
    Cell Death Differ; 2001 Apr 01; 8(4):411-24. PubMed ID: 11550093
    [Abstract] [Full Text] [Related]

  • 13. Hyperoxia induces Egr-1 expression through activation of extracellular signal-regulated kinase 1/2 pathway.
    Jones N, Agani FH.
    J Cell Physiol; 2003 Aug 01; 196(2):326-33. PubMed ID: 12811826
    [Abstract] [Full Text] [Related]

  • 14. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J.
    Invest Ophthalmol Vis Sci; 2008 Feb 01; 49(2):497-504. PubMed ID: 18234991
    [Abstract] [Full Text] [Related]

  • 15. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis.
    Day RM, Cioce V, Breckenridge D, Castagnino P, Bottaro DP.
    Oncogene; 1999 Jun 03; 18(22):3399-406. PubMed ID: 10362361
    [Abstract] [Full Text] [Related]

  • 16. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W.
    Oncogene; 1992 Nov 03; 7(11):2195-206. PubMed ID: 1331934
    [Abstract] [Full Text] [Related]

  • 17. Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1.
    Zhang X, Liu Y.
    Am J Physiol Renal Physiol; 2003 Jun 03; 284(6):F1216-25. PubMed ID: 12569082
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 20. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Jul 15; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.